These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17403615)

  • 1. When killers become helpers.
    Hanna J; Mandelboim O
    Trends Immunol; 2007 May; 28(5):201-6. PubMed ID: 17403615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The unique properties of human NK cells in the uterine mucosa.
    Manaster I; Mandelboim O
    Placenta; 2008 Mar; 29 Suppl A():S60-6. PubMed ID: 18039547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NK cells contribute to the skin graft rejection promoted by CD4+ T cells activated through the indirect allorecognition pathway.
    Ito A; Shimura H; Nitahara A; Tomiyama K; Ito M; Kanekura T; Okumura K; Yagita H; Kawai K
    Int Immunol; 2008 Oct; 20(10):1343-9. PubMed ID: 18697765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer (NK) cell functions can be strongly boosted by activated dendritic cells (DC).
    Granucci F; Zanoni I; Ricciardi-Castagnoli P
    Eur J Immunol; 2006 Oct; 36(10):2819-20. PubMed ID: 17013979
    [No Abstract]   [Full Text] [Related]  

  • 5. Functions of natural killer cells.
    Vivier E; Tomasello E; Baratin M; Walzer T; Ugolini S
    Nat Immunol; 2008 May; 9(5):503-10. PubMed ID: 18425107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerant T cells inhibit natural killer cells function in antigen-presenting cells in an independent fashion.
    Wang X; Yuan J; Hu J; Wu J; Gan C; He W; Luo G
    Transplant Proc; 2009 Jun; 41(5):1844-7. PubMed ID: 19545741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developmental pathways that generate natural-killer-cell diversity in mice and humans.
    Huntington ND; Vosshenrich CA; Di Santo JP
    Nat Rev Immunol; 2007 Sep; 7(9):703-14. PubMed ID: 17717540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galectin-9 expands unique macrophages exhibiting plasmacytoid dendritic cell-like phenotypes that activate NK cells in tumor-bearing mice.
    Nobumoto A; Oomizu S; Arikawa T; Katoh S; Nagahara K; Miyake M; Nishi N; Takeshita K; Niki T; Yamauchi A; Hirashima M
    Clin Immunol; 2009 Mar; 130(3):322-30. PubMed ID: 18974023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NKG2D and natural cytotoxicity receptors are involved in natural killer cell interaction with self-antigen presenting cells and stromal cells.
    Poggi A; Prevosto C; Zancolli M; Canevali P; Musso A; Zocchi MR
    Ann N Y Acad Sci; 2007 Aug; 1109():47-57. PubMed ID: 17785290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer (NK) cells from killers to regulators: distinct features between peripheral blood and decidual NK cells.
    Santoni A; Zingoni A; Cerboni C; Gismondi A
    Am J Reprod Immunol; 2007 Sep; 58(3):280-8. PubMed ID: 17681044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [IKDC: killer dendritic cells or antigen-presenting NK cells?].
    Zitvogel L; Mignot G; Bonmort M; Ullrich E; Chaput N
    Med Sci (Paris); 2008 May; 24(5):525-8. PubMed ID: 18466731
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of NK and NKT cells in solid organ transplantation.
    Pratschke J; Stauch D; Kotsch K
    Transpl Int; 2009 Sep; 22(9):859-68. PubMed ID: 19386078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Research on immunological activity of non-immunological cells of decidua in normal early pregnancy].
    Hu D; Chen Z; Yan J
    Zhonghua Fu Chan Ke Za Zhi; 1999 Sep; 34(9):533-5. PubMed ID: 11360637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated T cells inhibit NK cell-mediated tumour rejection.
    Wang XJ; Hu J; Yuan J; Peng YM; Gui L; He WF; Tan J; Luo GX; Wu J
    Scand J Immunol; 2009 Apr; 69(4):337-41. PubMed ID: 19284498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate Valpha14(+) natural killer T cells mature dendritic cells, leading to strong adaptive immunity.
    Fujii S; Shimizu K; Hemmi H; Steinman RM
    Immunol Rev; 2007 Dec; 220():183-98. PubMed ID: 17979847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human NK cells: from HLA class I-specific killer Ig-like receptors to the therapy of acute leukemias.
    Moretta A; Locatelli F; Moretta L
    Immunol Rev; 2008 Aug; 224():58-69. PubMed ID: 18759920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids.
    Paget C; Mallevaey T; Speak AO; Torres D; Fontaine J; Sheehan KC; Capron M; Ryffel B; Faveeuw C; Leite de Moraes M; Platt F; Trottein F
    Immunity; 2007 Oct; 27(4):597-609. PubMed ID: 17950005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding how Tregs are regulated: therapeutic implications.
    Yuan X; Sayegh MH; Iacomini J
    Transplantation; 2009 Nov; 88(10):1159-60. PubMed ID: 19935368
    [No Abstract]   [Full Text] [Related]  

  • 19. Killers and beyond: NK-cell-mediated control of immune responses.
    Andoniou CE; Coudert JD; Degli-Esposti MA
    Eur J Immunol; 2008 Nov; 38(11):2938-42. PubMed ID: 18979519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xenotransplantation: role of natural immunity.
    Li S; Waer M; Billiau AD
    Transpl Immunol; 2009 Jun; 21(2):70-4. PubMed ID: 18992342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.